Sanofi denies abuse of FDA’s Orange Book

Davide Mamone

19 September 2023

Sanofi-Aventis says that Mylan Pharmaceuticals’ allegations that it illegally cornered the market for long-lasting insulin are merely a mishmash of “antitrust buzz words”.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Davide Mamone

View full biography

Author | News reporter, GCR USA

[email protected]

Tipline

Dodgy dealings: The Tipline for 25 September 2023
It is not clear that the entire Democratic party is on board with the Biden Administration’s desire to promote competition. The Department of Justice charged Senator Robert Menendez on Friday with accepting hundreds of thousands of dollars worth of bribes. Among other things, the DOJ says a New Jersey business paid Menendez to urge US food regulators to stop complaining about its monopoly over certifying meat shipped to Egypt as halal compliant. Also in …
Catching Kelce: The Tipline for 22 September 2023
Cruising for a bruising: The Tipline for 21 September 2023

Sanofi denies abuse of FDA’s Orange Book

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Davide Mamone